A clinical trail to study the effect of drug LAVANKATHI CHOORANAM on Iya iraippu noi Bronchial Asthma

A prospective open labelled randomized clinical trial on "IYA IRAIPPU NOI" (Bronchial Asthma) with evaluation of trial drug "Lavankathi Chooranam)

Status

Recruiting

Phases

Phase 2

Study type

Observational

Source

CTRI

Registry ID

CTRI/2018/04/013233

Enrollment

Registered

2018-04-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- IYA IRAIPPU NOI BRONCHIAL ASTHMA

Interventions

Intervention1: LAVANKATHI CHOORANAM: 6g two time per day for 20 days

Eligibility

Inclusion criteria

Inclusion criteria: Difficulty in Breathing Tightness of Chest Wheeze - Add Sound (Rhonchi) Cough without Expectoration H/O Allergy, Sneezing PEFR Male - From 250 l/min to 150 l/min Female - From 250 l/min to 100 l/min Spirometer Study

Exclusion criteria

Exclusion criteria: Cardiac Diseases Renal Desease Tuberculosis COPD Status Asthmaticus Diabetes Mellitus hypertension Pragnancy Lactating Mothers

Design outcomes

Primary

Measure	Time frame
To Evaluate the Therapeutic efficacy of LAVANKATHI CHOORANAM in the Treatment of IYA IRAIPPU NOITimepoint: 20 Days	—

Secondary

Measure	Time frame
To Evaluate the Siddha Cofactor Toword the Efficacy of the Traial Drug in the LAVANKATHI CHOORANAM and to Evalute the Pharmacological ActionTimepoint: 40	—

Countries

India

Contacts

Public ContactDR A MANOHARAN MD Siddha

Government Siddha Medical College and Hospital

drmanoharan25@gmail.com9443886700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026